Renal hemodynamic effects elicited by acute cyclooxygenase-2 inhibition are not related to angiotensin II levels

American Journal of Physiology - Renal Physiology

Volumn 299, Issue 5, 2010, Pages

  Salazar, F Javier ^a   Llinas, María T ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CYCLOOXYGENASE 2;

ANGIOTENSIN BLOOD LEVEL; EDITORIAL; ENZYME INHIBITION; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 78349250517     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00489.2010     Document Type: Editorial

References (17)

1. Bach PH, Nguyen TK. Renal papillary necrosis - 40 years on. Toxicol Pathol 26: 71-91, 1998.
2. Bertolini A, Ottani A, Sandrini M. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr Med Chem 9: 1033-1043, 2002.
3. Carrol MA, Kemp R, Cheng MK, McGiff JC. Regulation of preglomerular microvascular 20-hydroxyeicosatetraenoic acid levels. Med Sci Monit 7: 567-572, 2001.
4. Chatziantoniou C, Arendshorst WJ. Prostaglandin interactions with angiotensin, norepinephrine, and thromboxane in rat renal vasculature. Am J Physiol Renal Fluid Electrolyte Physiol 262: F68-F76, 1992.
5. Green T, Rodriguez J, Navar LG. Augmented cyclooxygenase-2 effects on renal function during varying states of angiotensin II. Am J Physiol Renal Physiol (First published July 28, 2010). doi:10.1152/ajprenal.00609.2009).
6. Hao CM, Breyer MD. Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Intern 71: 1105-1115, 2007.
7. Hao CM, Breyer MD. Physiological regulation of prostaglandins in the kidney. Annu Rev Physiol 70: 357-377, 2008.
8. Llinás MT, González JD, Nava E, Salazar FJ. Role of angiotensin II in the renal effects induced by nitric oxide and prostaglandins synthesis inhibition. J Am Soc Nephrol 8: 543-550, 1997.
9. Llinás MT, López R, Rodríguez F, Roig F, Salazar FJ. Role of cyclooxygenase-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine. Am J Physiol Renal Physiol 281: F975-F982, 2000.
10. López R, Roig F, Llinás MT, Salazar FJ. Role of cyclooxygenase-2 in the control of renal hemodynamics and excretory function. Acta Physiol Scand 177: 429-435, 2003.
11. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 76: 425-436, 1996.
12. Qi Z, Cai H, Morrow JD, Breyer MD. Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta. Hypertension 48: 323-328, 2006.
13. Rodríguez F, Llinás MT, González JD, Rivera J, Salazar FJ. Renal changes induced by a COX-2 inhibitor during normal and low sodium intake. Hypertension 36: 276-281, 2000.
14. Roig F, Llinás MT, Lopez R, Salazar FJ. Role of cyclooxygenase-2 in the prolonged regulation of renal function. Hypertension 40: 721-728, 2002.
15. Solomon DH, Schneeweiss Levin R, Avorn J. Relationship between COX-2 specific inhibitors and hypertension. Hypertension 44: 140-145, 2004.
16. Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, Pinto MB, Dilzer SC, Obrda O, Ebel DL, Quan H, Larson PJ, Schwartz JI, Gertz BJ, Brater DC, Yao SL. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low salt diet: a randomized, controlled trial. Ann Intern Med 4: 1-9, 2000.
17. Yang T, Singh Pham H, Sun D, Smart A, Schnermann JB, Briggs JP. Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol Renal Physiol 274: F481-F489, 1998.